Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

369
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
369
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

340
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
340
Cancer Survival Analysis01:21

Cancer Survival Analysis

491
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
491
Survival Tree01:19

Survival Tree

200
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
200
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

463
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
463
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

226
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Principal stratification with U-statistics under principal ignorability.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2026
Same author

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
Same author

A Survey on 3D Gaussian Splatting Applications: Segmentation, Editing, and Generation.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

Time-Varying Treatment Effect Models in Stepped-Wedge Cluster-Randomized Trials With Multiple Interventions.

Statistics in medicine·2026
Same author

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual- and Cluster-Randomized Trials.

Statistics in medicine·2026

Related Experiment Video

Updated: Nov 2, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K

Estimating heterogeneous survival treatment effect in observational data using machine learning.

Liangyuan Hu1,2, Jiayi Ji1, Fan Li3,4

  • 1Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Statistics in Medicine
|June 11, 2021
PubMed
Summary
This summary is machine-generated.

The nonparametric Bayesian Additive Regression Trees (AFT-BART-NP) method excels at estimating heterogeneous treatment effects in survival data. This machine learning approach offers improved accuracy and reliable confidence intervals for personalized treatment strategies.

Keywords:
Bayesian additive regression treescausal inferencemachine learningobservational studiessurvival treatment effect heterogeneity

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

301

Related Experiment Videos

Last Updated: Nov 2, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

301

Area of Science:

  • Biostatistics
  • Machine Learning
  • Causal Inference

Background:

  • Estimating heterogeneous treatment effects (HTE) with survival outcomes using observational data is challenging.
  • Existing methods have primarily focused on continuous or binary outcomes, with less validation for survival data.
  • Flexible machine learning (ML) in the counterfactual framework offers a promising avenue for HTE estimation tailored to individual characteristics.

Purpose of the Study:

  • To evaluate the performance of recent survival ML methods for HTE estimation.
  • To provide guidance for best practices in analyzing confounded heterogeneous survival treatment effects.
  • To assess the impact of varying covariate overlap on method performance.

Main Methods:

  • A comprehensive simulation study was conducted across diverse settings.
  • Methods evaluated included flexible ML approaches within a counterfactual framework.
  • The nonparametric Bayesian Additive Regression Trees (AFT-BART-NP) under the accelerated failure time model was a key focus.

Main Results:

  • AFT-BART-NP demonstrated superior performance regarding bias, precision, and expected regret.
  • Credible intervals from AFT-BART-NP achieved near-nominal frequentist coverage for individual treatment effects with moderate covariate overlap.
  • Incorporating a nonparametrically estimated propensity score improved AFT-BART-NP's efficiency and coverage.

Conclusions:

  • AFT-BART-NP is a robust and effective method for estimating HTE in survival data.
  • The method provides reliable uncertainty quantification, crucial for personalized medicine.
  • Flexible causal ML estimators, like AFT-BART-NP, are valuable tools for real-world applications, as shown in the prostate cancer radiotherapy case study.